↓ Skip to main content

Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

Overview of attention for article published in BMC Psychiatry, January 2013
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
Published in
BMC Psychiatry, January 2013
DOI 10.1186/1471-244x-13-39
Pubmed ID
Authors

Greg W Mattingly, Richard H Weisler, Joel Young, Ben Adeyi, Bryan Dirks, Thomas Babcock, Robert Lasser, Brian Scheckner, David W Goodman

Abstract

Despite the overall high degree of response to pharmacotherapy, consensus is lacking on how to judge clinical response or define optimal treatment/remission when treating adults with attention-deficit/hyperactivity disorder (ADHD). This study examined clinical response and symptomatic remission in analyses of 2 studies of lisdexamfetamine dimesylate (LDX) in adults with ADHD.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 3%
Canada 1 1%
United States 1 1%
Unknown 69 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 18%
Student > Bachelor 10 14%
Researcher 8 11%
Student > Doctoral Student 6 8%
Other 4 5%
Other 12 16%
Unknown 20 27%
Readers by discipline Count As %
Medicine and Dentistry 17 23%
Psychology 14 19%
Business, Management and Accounting 5 7%
Neuroscience 3 4%
Agricultural and Biological Sciences 3 4%
Other 10 14%
Unknown 21 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2013.
All research outputs
#17,677,535
of 22,694,633 outputs
Outputs from BMC Psychiatry
#3,628
of 4,641 outputs
Outputs of similar age
#211,243
of 282,817 outputs
Outputs of similar age from BMC Psychiatry
#85
of 93 outputs
Altmetric has tracked 22,694,633 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,641 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,817 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.